Details for 2017196662

Up to date per 02.04.2026

Actions

Title / Product Name

MODIFIZIERTE AXL-PEPTIDE UND DEREN VERWENDUNG IN DER HEMMUNG DER AXL-SIGNALISIERUNG IN EINER ANTIMETASTATISCHEN THERAPIE

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2017196662

EP Publication Number

3326622

E-Number

1355740

Language

PCT Number

Publication Date

30.05.2018 A

20.01.2021 B1

Registration Date

20.01.2021

AT Publication Date

15.02.2021

Application Date

12.12.2013

Registration Number

Priorities

14.12.2012

201261737276 P

IPC

A61K 31/00 20060101AFI20180219BHEP

Maximum Duration of Protection

12.12.2033

Owner

The Board of Trustees of the Leland Stanford Junior UniversityOffice of the General Counsel Building 170, Third Floor, Main Quad P.O. Box 20386 Stanford, CA 94305-2038US

Aravive Biologics, Inc.River Oaks Tower 3730 Kirby Drive Suite 1200 Houston, TX 77098US

Representative

Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Eingang Kirchengasse 1)1070 WienAT

Inventor

GIACCIA, Amato J.856 Esplanada Way Stanford, CA California 94305US

RANKIN, Erinn Bruno271 Ridge Lane Apt. 314 Waltham, MA Massachusetts 02452US

COCHRAN, Jennifer R.86 Peter Coutts Circle Stanford, CA California 94305US

JONES, Douglas48 Hawthorn Street Newton, MA Massachusetts 02458US

KARIOLIS, Mihalis177 N. El Camino Real 16 San Mateo, CA California 94401US

FUH, Katherine4909 Laclede Avenue, Unit 1806 St. Louis, MO Missouri 63108US

MIAO, Yu125 Connemara Way Apt. 116 Sunnyvale, CA California 94087US

HERSHENSON, Susan550 Hamilton Avenue Suite 220 Palo Alto, CA California 94301US